The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Client Messenger now available for ALL eFile submissions
-
We are excited to announce that ALL eFiles submission are now eligible for Client Messenger!
Messenger allows you to receive binding review decisions on pivotal segments of your piece within 1 business day.
To request Client Messenger, select ‘yes’ on the submission form field ‘Request Messenger Fee”. Please note that Messenger can also be requested after initial submission by contacting review@paab.ca.
Want to learn more about Client Messenger and see some examples of when it can be used to help augment the speed of review? Visit our Administrative Guidelines for Client Messenger Use.
We hope to message with you soon!
The PAAB team.